United States · Investor

Savitr Capital

Last cheque observed Sep 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietInvestment firm

Series BEnergyInformation Technology

Cheques on record
0%of best year0cheques in 12 months, 3 on record
Since the last cheque2602days00hrs00min00sec
Median round$20MRounds led0 of 3Sole investor2 roundsExits1 from the portfolio
Pitch Savitr Capital

Savitr Capital highlights

  1. 01

    3 rounds on record

  2. 02

    Mostly Series B: 100% of its rounds

  3. 03

    Sole investor in 2 rounds, median $20M

  4. 04

    1 exits from the portfolio

What they do

Type
Investment firm (from a list, unverified)
Cheque size
Not stated
Sectors
EnergyInformation Technology
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first3 appearances

  1. 2019

    1 round

  2. Sept
    OncoCell MDxSeries B · US · FinSMEs$22MSole investor
  3. 2018

    1 round

  4. May
    AncoraUS · FinSMEs$18MSole investor
  5. 2012

    1 round

  6. Dec
    NaurexSeries B · US · fiercebiotech.com$38MWith 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What they claim to have backed

From their own portfolio page (on their website)

3 of 10 we have independently watched raise

BioIQ -ImmunissvelteApex -Bulletin Intelligence -GlytecInitialNaurex -emeraldbiotavanta

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

NaurexBought by Allergan$560MJul 2015

An exit counts when it came after the firm's first round in the company. From historical deal records.

Recently backed

The latest companies Savitr Capital put money into.

Quick answers about Savitr Capital

What does Savitr Capital invest in?

Savitr Capital invests most often at Series B (100% of the rounds on record), in sectors such as Energy and Information Technology.

How active is Savitr Capital?

3 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2019.

What has Savitr Capital invested in recently?

Its most recent investments on record: OncoCell MDx (Series B, Sept 2019) and Ancora (Undisclosed round, May 2018).

How big are Savitr Capital's cheques?

The median round it joins is $20M.

Is Savitr Capital investing now?

No investments in the last 12 months; the latest was in Sept 2019.

What kind of investor is Savitr Capital?

Savitr Capital is an investment firm based in United States.

Where does this information on Savitr Capital come from?

From 3 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it